Havana, Dec 29 (ACN) Colombia’s Health Ministry authorized the use of the Cuban Cancer pharmaceutical CIMAher in the country’s health program, according to BioCubaFarma Biotech Conglomerate.
The approval of the use of the Cuban product now allows Colombian doctors to prescribe it for the population, said BioCubaFarma on its Twitter account.
CIMAher is a humanized antibody, used on patients suffering from esophagus cancer with no chance for surgery. The drug is combined with Chemotherapy. A study on such cancer patients treated with the Cuban pharmaceutical combined with chemo resulted in good response values for survival.
According to an article published by the Cuban Health Network INFOMED the control rate of the disease reached 83 percent, and the objective response rate went up to 64 percent in he group of patients with advanced esophagus cancer.
Nos reservamos el derecho de no publicar los comentario que incumplan con las normas de este sitio